Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 878 results for "food and drug authority"

Bedaquiline approved to treat multi-drug resistant tuberculosis
BDlive

The FDA Drug Approval Process in the Lifecycle of a Pre-Sales ...

The U.S. Food & Drug Administration regulates new drug approvals in a process that is extremely thorough, lengthy and expensive. Regulations apply to a drug candidate's product development phase, the approval process and after approval. Failure to ... JD Supra, 2 days ago

3 images for "food and drug authority"

Jamaica Gleaner, 3 days ago
Columbus Republic, 5 days ago
Chicago Daily Herald, 6 days ago

Many Recalled Supplements Remain on the Market

Many dietary supplements remain on the retail market months after they were recalled by the US Food and Drug Administration (FDA) because they contained banned pharmaceutical ingredients, according to a research letter published in the October 22/29 ...
 General Medicine eJournal16 hours ago Industry Responds to JAMA Letter on Adulterated Supplements  Nutraceuticals World13 hours ago JAMA Finds Spiked Supplements Still on the Market after FDA Recalls  Nutritional Outlook21 hours ago Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets  Biotechgate1 week ago

Recalled, drug-tainted supplements still available for purchase

NEW YORK (Reuters Health) - Long after the Food and Drug Administration (FDA) issued recalls for dietary supplements tainted with banned drugs, more than half of the tainted supplements were still available for purchase, a new study found. There's ...
 Yahoo! India1 day ago FDA recalls eight more Ting Hsin Oil products  Taipei Times Online19 hours ago
[x]  

NOVARTIS : FDA Advisory Committee Recommends Approval of AIN457 (secukinumab) for Patients with Moderate-to-severe Plaque Psoriasis

Novartis reported the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) to the US Food and Drug Administration (FDA) voted 7 to 0 to support the approval of AIN457 (secukinumab), a selective interleukin-17A (IL-17A) inhibitor, for the ...
 4 Traders7 hours ago FDA committee unanimously recommends approval of AIN457 for psoriasis treatment  Orthopedics Today15 hours ago FDA Panel Backs Novartis' Psoriasis Drug  RTTNews.com2 days ago Novartis: FDA Advisory Committee Recommends Approval of AIN457 (secukinumab) for Patients with Moderate-to-severe Plaque Psoriasis  Individual.com7 hours ago
Huffington Post

Chimerix Gets FDA OK to Test Drug for Ebola

A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration. Chimerix Inc. said Thursday that it has received FDA clearance ...
 ABC News5 days ago Drug That Lost High-Stakes Political Fight For Funding Now Being Used Against Ebola  Huffington Post1 day ago FDA Allows Testing of Ebola Experimental Drug by Chimerix  American Journal of Managed Care5 days ago CBS Health: FDA approves testing new Ebola drug  CBS News5 days ago
[x]  

'No harmful bacteria found in Dongsuh cereals'

By Kim Rahn The health authorities said Tuesday that its most recent testing of Dongsuh Food's cereal products found no coliform bacteria. Previous tests had found that the company had reused contaminated cereal. Officials at the Ministry of ...
 Korea Times2 days ago Authorities shed light on E. coli fears  Joins.com1 day ago
Med India

US FDA accepts Eisai's sNDA for antiepileptic drug, fycompa to treat primary generalised tonic-clonic seizures

The US Food and Drug Administration (US FDA) has accepted for review the Eisai's supplemental New Drug Application (sNDA)for its in-house developed antiepileptic drug Fycompa (perampanel)for the treatment of primary generalised tonic-clonic seizures ...
 PharmaBiz1 day ago New Inhaled Drug Accredited to Treat Chronic Obstructive Pulmonary Disease  Med India2 months ago Eisai : U.S. FDA ACCEPTS sNDA FOR ANTIEPILEPTIC AGENT FYCOMPA AS ADJUNCTIVE TREATMENT OF PRIMARY GENERALIZED TONIC-CLONIC SEIZURES  4 Traders2 days ago U.S. FDA Grants Priority Review Status to NDA for Anticancer Agent Lenvatinib  Drugs.com2 days ago

Maharashtra FDA detects over 20 cases of illegal sale of prescription drugs

Maharashtra Food and Drug Administration (FDA) has detected over 20 cases of illegal sale of Codeine containing cough syrups to drug addicts in huge quantities without a prescription and without issuing a sales bill. Official reports indicate that ...
 PharmaBiz2 days ago
Review Seeker

ISPE unveils plan to prevent drug shortages

Regulators from the European Medicines, the US Food and Drug Administration and the UK's Medicines and Healthcare Products Regulatory Agency (MHRA), welcomed the Drug Shortages Prevention Plan, which was released by the International Society for ...
 Pharma Letter6 days ago ISPE Plan to Prevent Drug Shortages released at Annual Meeting  Review Seeker1 week ago ISPE Releases Drug Shortages Prevention Plan  Pharmaceutical Online6 days ago ISPE launches plan to prevent drug shortages  Manufacturing Chemist1 week ago
[x]  

AIDS activist takes up a new fight: defending FDA

As an AIDS activist in the early 1990s, Gregg Gonsalves traveled to Washington to challenge the Food and Drug Administration. Gonsalves was part of the confrontational group AIDS Coalition to Unleash Power, which staged protests outside the FDA's ...
 Sify2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less